CONTEXT: Commercial announcement of Picnic Health and Komodo Health partnership to support RWE programs for complex illnesses like MS and haemophilia. IMPACT: Low READ TIME: 1 min Quality Level Mean Continue Reading
CONTEXT: RWE data presented at the Digestive Disease Week (DDW) 2021 evaluated the prevalence and predictors of immunomodulator use as concomitant therapy with two commonly prescribed biologics. IMPACT: Low Continue Reading
CONTEXT: Commercial announcement of a collaboration on RWE generation in migraine. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 6 1. “” Our ongoing partnership enables Continue Reading
CONTEXT: Commercial announcement of a collaboration on RWE generation in migraine. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 6 1. “” Our ongoing partnership enables Continue Reading
CONTEXT: Publication of abstracts through ASCO on patient derived RWE on two very interesting areas of oncology. The first abstract looks at the reasons behind the low levels of trial Continue Reading
CONTEXT: An opinion piece on why more RWE is needed on how patients respond to biosimilars in oncology | “More evidence is the tool for persuading oncology providers to switch Continue Reading
CONTEXT: Roche going big on data at this years ASCO. Multiple RWE studies presented across their oncology portfolio. IMPACT: Medium READ TIME: 2 mins Quality Level Mean [1 – 10]: Continue Reading
CONTEXT: Report of data presented at the EuroPCR annual meeting on Medtronic’s Symplicity Renal Denervation system. Results from a registry involving nearly 3,000 patients showed significant and clinically meaningful reductions Continue Reading
CONTEXT: Publication of a retrospective chart review on the effectiveness of Halaven (eribulin mesylate) in metastatic breast cancer | One of the limitations of this study is that detailed safety Continue Reading
CONTEXT: Results from the analysis of registry involving around 6,000 TAVR patients in the US. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – 10]: 6 1. “(TVT) Continue Reading
